Recombinant SAA1 antibody
Quick Overview for Recombinant SAA1 antibody (ABIN7581776)
Target
See all SAA1 AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Grade
Clone
-
-
Expression System
- Phage display
-
Purpose
- Mouse anti- human Serum Amyloid A1
-
Specificity
- This is an antibody developed by antibody phage display technology using a human naive antibody gene library and human serum amyloid A1 antigen. For this antibody both the heavy and light chains are cloned and expressed, generating full-length antibodies.
-
Characteristics
- This antibody can be detected with anti-mouse Fc secondary antibodies.
-
Purification
- Protein A purification
-
Immunogen
- No immunization, animal-free antibody development. Antigen: human serum amyloid A1
-
Isotype
- IgG2a
-
-
-
-
Application Notes
- ELISA: 1-12 μg/mL as coating antibody 0.5-5 μg/mL as detection antibody Optimal working dilution should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, pH 7.4,
-
Storage
- -20 °C
-
-
- SAA1 (Serum Amyloid A1 (SAA1))
-
Alternative Name
- Serum Amyloid A1
-
Background
- Serum Amyloid A1 (SAA1) is a prominent acute-phase protein in humans, primarily produced by the liver in response to inflammation. It plays a role in the immune system, potentially aiding in tissue repair, acting as an antibacterial agent, and signaling the migration of immune cells to sites of infection. Levels of SAA1 can increase dramatically (up to 1000-fold) during inflammatory states triggered by infections, injury, or chronic diseases.
-
Molecular Weight
- 12 kDa
-
Gene ID
- 6822
-
NCBI Accession
- NG_012021
-
UniProt
- P02647
-
Pathways
- Toll-Like Receptors Cascades
Target
-